Table 4.
Susceptibility of E. coli K-12 substr. MG1655 ΔacrB ΔacrF following complementation with acrF from E. coli K-12 substr. MG1655 and E. coli O157:H7 (ST11)
MIC (µg ml−1) |
|||
---|---|---|---|
Strain |
ERY |
R6G |
EtBr |
E. coli ATCC 25922 |
64 |
1024 |
256 |
E. coli K-12 substr. MG1655 |
64 |
512 |
512 |
E. coli K-12 substr. MG1655 ΔacrB |
4 |
8 |
8 |
E. coli K-12 substr. MG1655 ΔacrB ΔacrF |
4 |
8 |
8 |
E. coli K-12 substr. MG1655 ΔacrB ΔacrF+pET21 a |
4 |
16 |
8 |
E. coli K-12 substr. MG1655 ΔacrB ΔacrF+pET21 a K-12 sequence |
8 |
64 |
64 |
E. coli K-12 substr. MG1655 ΔacrB ΔacrF+pET21 a ST11 sequence |
4 |
16 |
8 |
ERY, erythromycin; EtBr, ethidium bromide; R6G, rhodamine 6G.